Simon N.R. Harford - Jul 13, 2021 Form 4 Insider Report for ALBIREO PHARMA, INC. (ALBO)

Role
CFO and Treasurer
Signature
/s/ Jason Duncan, Attorney-in-fact
Stock symbol
ALBO
Transactions as of
Jul 13, 2021
Transactions value $
-$3,432
Form type
4
Date filed
7/15/2021, 04:48 PM
Next filing
Oct 12, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Sale -$3.43K -98 -0.77% $35.02 12.7K Jul 13, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 Represents 5,644 shares of common stock and 7,063 restricted stock units. Includes 609 shares of common stock acquired under the Albireo Pharma, Inc. 2018 Employee Stock Purchase Plan (the "ESPP") on May 31, 2021.